Across TCGA pan-cancer cohorts, DNAJC19P6 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of DNAJC19P6’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where DNAJC19P6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DNAJC19P6 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

BLCA and THCA are the cancer types where DNAJC19P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DNAJC19P6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.130	.019	5	view →
THCA	All	All	−0.064	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: DNAJC19P6 RNA expression & survival · all DNAJC19P6 data types